Healthpoint, the super-speciality destination hospital in Abu Dhabi, and the Imperial College London Diabetes Centre have announced a strategic collaboration to jointly treat patients suffering from obesity, providing comprehensive expertise in treatment and care that includes obesity management and bariatric surgery.
Both parts of Mubadala’s healthcare network, the partnership between Healthpoint and the Imperial College London Diabetes Centre bring super-specialty care to patients by addressing the complex and individual needs of obese people. With the partnership, Healthpoint’s Bariatric and Metabolic Surgery Centre treats obese patients who require specialist services in collaboration with Imperial College London Diabetes Centre to provide a multi-disciplinary approach in tackling the disease and related complications. Patients identified as good candidates for surgery follow a program of dietary education and psychological support tailored to suit their needs. With the combined strength of both organisations, patients are assured of continuous care and extensive follow up post-surgery.
Obesity is a growing epidemic throughout the Middle East, affecting men, women and children. According to a study by the Health Metrics and Evaluation Institute, more than 58 percent of men and 65 percent of women in the region are considered overweight or obese and a growing number of children are battling weight issues from a young age. Here in the UAE, rates of obesity are twice the global average, and in fact, expatriates often double their obesity rate within 5 years of relocating here. Obesity can lead to a number of serious health complications if left untreated, including blindness, kidney failure, lower-limb amputation, and high blood pressure, and can also increase the likelihood of cardiovascular disease.
“With the alarming rate of obesity in the Middle East and the associated costs of care, we need to take a holistic approach to both prevention and treatment, creating programs that will help our patients, as well as the entire region. Obesity and associated complications place a huge burden on healthcare costs, as well as personnel costs, and it is up to medical institutions to find solutions in tackling this disease and helping individuals manage their treatment programs and avoid complications. As a leading institution for diabetes care, Imperial College London Diabetes Centre wants to maximize our expertise by cooperating with Healthpoint to come up with effective treatment plans that work and respond to our patients as individuals,” said Dr Saf Naqvi, Medical Director and Consultant Physician and Endocrinologist at ICLDC.
ICLDC’s on-site team of dietitians and specialists collaborate with Healthpoint’s experts to provide monitoring, support and education to patients seeking weight loss surgery, as well as to those who have already undergone weight loss surgery.
Dr. Mohammed Al Hadad, Consultant General Surgeon and head of the Bariatric & Metabolic Surgery Centre at Healthpoint said: “Undergoing bariatric surgery is a lifelong commitment. Healthpoint surgeons and my team, along with Imperial College London Diabetes Centre physicians work hand in hand to ensure that the patient is taken care of for life and not just in time for surgery. This program is the first of its kind and creates the best possible outcome for patients suffering from diabetes and obesity. It is very rewarding for us to witness how successful this approach is and how it is changing our patients’ lives.”
As one of the four centres of clinical excellence at Healthpoint, the Bariatric & Metabolic Surgery Centre has expertise in delivering world-class services to obese patients who suffer from diabetes and need a life-changing solution.
Healthpoint, part of Mubadala’s network of world-class healthcare providers, is a super-specialty integrated practice hospital located in Zayed Sports City, Abu Dhabi. Healthpoint is home to four centers of clinical excellence: Abu Dhabi Knee & Sports Medicine Centre, Wooridul Spine Centre, the Bariatric & Metabolic Surgery Centre, and the Plastic & Cosmetics Surgery Centre, as part of 21 clinical services covering a wide range of patient and community care, including pediatrics, dentistry and gynecology.
Serving the community since 2013, Healthpoint’s highly specialized medical experts and state-of-the-art facilities provide patients with full-cycle care – inpatient, out-patient and rehabilitative– that addresses the patients’ physical condition, as well as respecting their lifestyle, culture and overall wellbeing, to ensure that every patient is offered personalized care in a boutique, technologically-advanced environment.
Healthpoint is a public healthcare facility with a compassionate and dedicated team that offers accessible healthcare to everyone. Healthpoint is committed to providing quality care and education to empower patients and communities and give them the tools they need to lead healthier and happier lives.
About Imperial College London Diabetes Centre
Imperial College London Diabetes Centre is a one-stop, state-of-the-art, out-patient facility that specialises in diabetes treatment, research, training and public health awareness.
The Centre was established in Abu Dhabi by Mubadala Healthcare, in partnership with the UK’s Imperial College London, in 2006 to address the growing demand for diabetes care in the UAE. A second facility in Al Ain opened in 2011. Together, the Centres have offered diabetes prevention, education and treatment to more than 160,000 people.
‘Diabetes-Knowledge-Action’ is Imperial College London Diabetes Centre’s award-winning public health awareness campaign. It was launched in 2007 under the patronage of Her Highness Sheikha Fatima bint Mubarak.
Imperial College London Diabetes Centre holds the Joint Commission International (JCI) Clinical Care Program Certification (CCPC) in Diabetes Management and JCI Accreditation for Ambulatory Care, awarded in 2010 and again in 2013. The 2010 award made Imperial College London Diabetes Centre the only healthcare provider worldwide to hold both certifications and the first facility in the Middle East and third globally to hold JCI’s highly-acclaimed CCPC specifically for the clinical management of diabetes.
For more information log on to www.icldc.ae
About Mubadala Healthcare
Mubadala Development Company (Mubadala) is a catalyst for the economic diversification of the Emirate of Abu Dhabi. The company’s commercial strategy is built on the management of long-term, capital-intensive investments that deliver not only strong financial returns but tangible social benefits for the people of Abu Dhabi. In doing so, Mubadala is expanding the economic base of the Emirate and in turn, significantly contributing to the growth and diversification of the Abu Dhabi economy.
As a business unit of Mubadala Development Company, Mubadala Healthcare is playing an instrumental role in the creation of a thriving healthcare sector for the Emirate. By establishing partnerships with renowned international medical institutions, it is actively investing to develop healthcare services that provide patients with world-class treatment in their home country.
Mubadala Healthcare evaluates potential projects both on their likely commercial returns as well as on their socio-economic impact. It aims to establish sustainable businesses, build regional capability and stimulate the overall development of the sector. The first priority has been to address the region’s most pressing healthcare needs through the creation of specialist healthcare facilities. In collaboration with
medical organizations such as Johns Hopkins Medicine International, Imperial College London and Cleveland Clinic, the goal is to bring the highest standards of clinical expertise to the region and reduce the need for patients to travel abroad for treatment.
For more information, please visit www.mubadala.ae/portfolio/healthcare